Jeffrey Zhao, PhD joined NEJM 醫(yī)學前沿, as a founding deputy editor in 2016. He is responsible for the editorial operations and strategies, academic conferences and clinical research training program. He collaborated with editors and other functions from the NEJM Group for numerous projects, including the annual Artificial Intelligence in Medicine Symposium (AIMS). Previously, he was a full-time scientific editor at Nature Communications, managing the evaluation and review of worldwide submissions in epigenetics, bioinformatics, and molecular biology methods, among other areas. He fostered close relationships with researchers and clinicians from a broad range of medical and life sciences in China. He obtained a BSc from Peking University and a PhD from the University of Oregon. His postdoctoral training in the U.S. National Cancer Institute was centered on the epigenetic regulation of gene expression.